| Item Type | Name |
|
Concept
|
Hydrochlorothiazide
|
|
Academic Article
|
Pharmacogenomics of hypertension: a genome-wide, placebo-controlled cross-over study, using four classes of antihypertensive drugs.
|
|
Academic Article
|
Lack of association between polymorphisms in STK39, a putative thiazide response gene, and blood pressure response to hydrochlorothiazide.
|
|
Academic Article
|
Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic.
|
|
Academic Article
|
Lack of agreement between office and ambulatory blood pressure responses to hydrochlorothiazide.
|
|
Academic Article
|
Reproducibility of blood pressure response to hydrochlorothiazide.
|
|
Academic Article
|
Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.
|
|
Academic Article
|
Demographic, environmental, and genetic predictors of metabolic side effects of hydrochlorothiazide treatment in hypertensive subjects.
|
|
Academic Article
|
A multilocus approach to the antihypertensive pharmacogenetics of hydrochlorothiazide.
|
|
Academic Article
|
WNK1 kinase polymorphism and blood pressure response to a thiazide diuretic.
|
|
Academic Article
|
Effects of endothelial nitric oxide synthase, alpha-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide.
|
|
Academic Article
|
Pharmacogenomics of antihypertensive drugs: rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study.
|
|
Academic Article
|
The role of plasma renin activity, age, and race in selecting effective initial drug therapy for hypertension.
|
|
Academic Article
|
Predictors for glucose change in hypertensive participants following short-term treatment with atenolol or hydrochlorothiazide.
|
|
Academic Article
|
Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazide.
|
|
Academic Article
|
PROX1 gene variant is associated with fasting glucose change after antihypertensive treatment.
|
|
Academic Article
|
TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives.
|
|
Academic Article
|
Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response.
|
|
Academic Article
|
Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazide.
|
|
Academic Article
|
Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension.
|
|
Academic Article
|
G protein receptor kinase 4 polymorphisms: ß-blocker pharmacogenetics and treatment-related outcomes in hypertension.
|
|
Academic Article
|
Interacting effects of gender and genotype on blood pressure response to hydrochlorothiazide.
|
|
Academic Article
|
Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker.
|
|
Academic Article
|
Lack of correlation between thiazide-induced hyperglycemia and hypokalemia: subgroup analysis of results from the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.
|
|
Academic Article
|
Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications.
|
|
Academic Article
|
Comparison of office, ambulatory, and home blood pressure antihypertensive response to atenolol and hydrochlorthiazide.
|
|
Academic Article
|
A Genetic Response Score for Hydrochlorothiazide Use: Insights From Genomics and Metabolomics Integration.
|
|
Academic Article
|
Blood pressure responses and metabolic effects of hydrochlorothiazide and atenolol.
|
|
Academic Article
|
Night blood pressure responses to atenolol and hydrochlorothiazide in black and white patients with essential hypertension.
|
|
Academic Article
|
Genome-Wide and Gene-Based Meta-Analyses Identify Novel Loci Influencing Blood Pressure Response to Hydrochlorothiazide.
|
|
Academic Article
|
Genome-Wide Prioritization and Transcriptomics Reveal Novel Signatures Associated With Thiazide Diuretics Blood Pressure Response.
|
|
Academic Article
|
Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics.
|
|
Academic Article
|
Whole Transcriptome Sequencing Analyses Reveal Molecular Markers of Blood Pressure Response to Thiazide Diuretics.
|
|
Academic Article
|
Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses).
|
|
Academic Article
|
Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/ß-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.
|
|
Academic Article
|
Targeted sequencing identifies a missense variant in the BEST3 gene associated with antihypertensive response to hydrochlorothiazide.
|
|
Academic Article
|
Race-Specific Comparisons of Antihypertensive and Metabolic Effects of Hydrochlorothiazide and Chlorthalidone.
|
|
Academic Article
|
Pairwise comparison of hydrochlorothiazide and chlorthalidone responses among hypertensive patients.
|
|
Academic Article
|
Circulating microRNA Biomarkers of Thiazide Response in Hypertension.
|